Yeast Infections Clinical Trials

DO YOU HAVE VAGINAL SYMPTOMS? We are currently testing new investigational medications for vaginal infections. We are currently seeking women to participate in a research study. IF YOU HAVE ANY OF THE FOLLOWING SYMPTOMS, YOU MAY QUALIFY: Itching Burning Irritation Odor Discharge To be eligible, you must meet certain other ...

TRIAL DURATION = 30 DAYS PATIENTS REQUIRED: FEMALES 18-65 Y/O OPTIONAL 24H PK VISIT ON V4,DAY6 OF TRIAL NO PLACEBO ARM

"Vaginitis" (Bacterial Infection) is a medical term used to describe various conditions that cause infection or inflammation of the vagina. Vulvovaginitis refers to inflammation of both the vagina and vulva (the external female genitals). These conditions can result from a vaginal infection caused by organisms such as bacteria, yeast, or ...

The study will evaluate the efficacy and safety of oral VT-1161 capsules in the treatment of subjects with RVVC. The impact of oral VT-1161 treatment will also be evaluated using data collected from patient reported outcome assessments.

If you’ve had at least three yeast infections (also known as recurrent vulvovaginal candidiasis) in the last year, talk to us about the VIOLET clinical trial. We’re testing an investigational drug for women and girls (12+) facing the same challenges as you.  

Women’s Health Care Research is conducting a clinical trial for recurrent yeast infections.   Symptoms of a yeast infection include: Itching Irritation Burning  

Whatever you call it, it’s important to take your vagina’s health seriously. So, if you’ve had at least three yeast infections (also known as recurrent vulvovaginal candidiasis) in the last year, talk to us about the VIOLET clinical trial. We’re testing an investigational drug for women and girls (12+) facing the ...

To assess the safety of Ambisome 10 mg/kg/week in patients as a preemptive treatment in intensive care patients with a sepsis and rising candida colonisation. Preemptive treatment (i.e., prophylactic treatment with two high doses of Ambisome® administered with an interval of one week, in patiens with a high risk of ...

This study is designed for the evaluation, diagnosis, and long-term follow up of selected patients with primary immune deficiencies and other conditions associated with fungal, and more specifically with Candida spp. infections. The primary immune deficiencies to be studied include, but are not limited to, autoimmune polyendocrinopathy candidiasis ectodermal dystrophy ...

This protocol is a prospective, interventional, randomized, double-blind, placebo controlled longitudinal study designed to investigate the microbiomic and immunologic perturbations that lead to vulvovaginal candidiasis (VVC) in women who receive antibiotics. VVC is the most common fungal infection affecting women. Although asymptomatic vaginal Candida colonization occurs in ~10-20% of healthy ...